Cogent Biosciences, Inc. Quarterly Current Ratio in % from Q3 2018 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Cogent Biosciences, Inc. quarterly Current Ratio history and growth rate from Q3 2018 to Q3 2024.
  • Cogent Biosciences, Inc. Current Ratio for the quarter ending September 30, 2024 was 848 %, a 17.3% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 848 -177 -17.3% Sep 30, 2024
Q2 2024 915 -239 -20.7% Jun 30, 2024
Q1 2024 985 -142 -12.6% Mar 31, 2024
Q4 2023 933 -200 -17.6% Dec 31, 2023
Q3 2023 1.03K -187 -15.4% Sep 30, 2023
Q2 2023 1.15K -51 -4.24% Jun 30, 2023
Q1 2023 1.13K -167 -12.9% Mar 31, 2023
Q4 2022 1.13K -453 -28.6% Dec 31, 2022
Q3 2022 1.21K -539 -30.8% Sep 30, 2022
Q2 2022 1.2K -304 -20.1% Jun 30, 2022
Q1 2022 1.29K +19.3 +1.51% Mar 31, 2022
Q4 2021 1.59K +732 +85.6% Dec 31, 2021
Q3 2021 1.75K +1.3K +289% Sep 30, 2021
Q2 2021 1.51K +1.25K +479% Jun 30, 2021
Q1 2021 1.28K +1.03K +410% Mar 31, 2021
Q4 2020 854 +609 +248% Dec 31, 2020
Q3 2020 450 +193 +74.9% Sep 30, 2020
Q2 2020 260 -32.9 -11.2% Jun 30, 2020
Q1 2020 250 -79 -24% Mar 31, 2020
Q4 2019 246 -59.8 -19.6% Dec 31, 2019
Q3 2019 257 -52.2 -16.9% Sep 30, 2019
Q2 2019 293 Jun 30, 2019
Q1 2019 329 Mar 31, 2019
Q4 2018 306 Dec 31, 2018
Q3 2018 310 Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.